ISOO Ocular Surface Squamous Neoplasia (OSSN) Webinar
The next ISOO webinar focuses on ocular surface squamous neoplasia (OSSN), with international case presentations and discussion. Virtual and free for ISOO members.
Rb-NET Challenges 2026
The 5th Rb-NET Challenges Webinar will feature 5 rapid-fire "What Would You Do Next?" case presentations with live audience participation, followed by a real-life multidisciplinary team (MDT) challenge. 2 international teams, each with an ophthalmologist, pediatric oncologist, radiologist, and ocular pathologist, will receive the same clinical case and move into separate Zoom breakout rooms to discuss their approach. Everyone will then reconvene to compare decisions, see how the case evolved, and learn from one another. The webinar will last up to 2 hours.
Registration is required. Register through Zoom:
https://us06web.zoom.us/meeting/register/tfwVOBCDTwWGrgSiIgL47g
Learn more about Rb-NET: https://www.rb-net-mdt.org/
14th Ocular Oncology Day
The 14th Ocular Oncology Day brings together international specialists to share updates in clinical ocular oncology and exchange ideas on new therapies, research, and results.
Honorary President: Dr. Artur Klett
Local President: Dr. Doris Hadjistilianou
Advisory Board: Dr. Francis Munier, Dr. Hayyam Kıratlı
Scientific Chair: Dr. Rana'a Al-Jamal
Local Committee: Dr. Sonia De Francesco, Dr. Tommaso Padula, Dr. Chiara Ciurlo, Dr. Federica Sugamiele
President Lecture
Dr. Artur Klett: All About Enucleation
Key Lectures
Dr. Arun D. Singh: Retinoblastoma: Novel Route for Delivering Chemotherapy
Dr. Manoj Parulekar: Neovascular Complications of Retinoblastoma and Its Treatment
Dr. Marco Pellegrini: Seeing Beyond the Tumor: High-Resolution and Functional Imaging in Ocular Oncology
Invited Lectures
Dr. Jens Folke Kiilgaard: Evidence Based Follow-Up Program for Uveal Melanoma
Dr. Eva Biewald: Treatment Approaches in Retinoblastoma
Dr. Hayyam Kıratlı: Conjunctival Melanoma: A Round-Up and Beyond
Dr. Paula Niinimäki: Periorbital and Orbital Rare Malignant Tumors: What Lies Beneath
Dr. Ashwin Reddy: Improving Outcomes for Retinoblastoma Survivors
Basic Course Sessions
What Do Our Residents Know About Ocular Oncology? A Q&A with Experts
What Can a Neuroradiologist Add to the Diagnosis and Treatment Planning of Intraocular Tumors?
Will the Treatment of Uveal Melanoma Be the Same in 5 Years?
Rapid Regression of Ophthalmic Tumors: Challenging Cases and Clinical Pearls
Main Topics
Conjunctival tumors, orbital tumors, retinoblastoma, pediatric ophthalmology and ocular oncology complex cases, masquerade syndromes, uveal tumors, genetics, liquid biopsies, oculoplastics, imaging (ultrasound, OCT, and MRI), and new therapies in ocular oncology.
For registration and full program details, visit the official congress website: https://www.apmeetings.com/singolo_evento_sem.php?id=52
European Retinoblastoma Group (EURbG) Annual Meeting 2027
The European Retinoblastoma Group holds its annual meeting in Paris, hosted by Institut Curie, with working group sessions on May 19 and a joint retinoblastoma session with the Ophthalmic Oncology Group (OOG) on May 20. In person in Paris, France.
61st Ophthalmic Oncology Group (OOG) Annual Meeting 2027
Ocular oncologists from Europe and around the world meet in Paris for the 61st Ophthalmic Oncology Group Annual Meeting, hosted by Institut Curie. In person in Paris, France.
IOSC 2026 Ocular Oncology Symposium
The National University Hospital Department of Ophthalmology, Singapore, invites all ISOO members to attend this in-person Ocular Oncology Symposium. The program features international speakers, including Dr. Santosh Honavar and Dr. Jesse Berry.
Shields Oncology Rounds
Each month, 3 complex ocular oncology cases are presented and discussed by ophthalmologists from around the world, often referred for specialized expertise. The session draws a highly engaged international audience and continues to grow in influence. Presenters and topics rotate monthly, delivering focused case discussion centered on real world clinical decision making. Dr. Carol Shields and Dr. Sara Lally host each session and lead structured, interactive dialogue that reflects the clinical standards of the program.
Open to all ISOO members. No registration is required. Members join directly using the Zoom link:
https://us06web.zoom.us/j/89965332787?pwd=VaEakhwLzJElJxHbcteZbEn53YOHlX.1
3rd Ocular Oncology Happy Hour Symposium
Science, Sun & Symposium: 3rd Ocular Oncology Happy Hour is Coming!
One Retinoblastoma World 2026
Three-day global gathering of families, survivors, clinicians, and scientists advancing lifelong retinoblastoma care—held just before the 58th SIOP World Congress.
Shields Oncology Rounds
Each month, three complex ocular oncology cases are presented and discussed by ophthalmologists from around the world, often referred for specialized expertise. The session draws a highly engaged international audience and continues to grow in influence. Presenters and topics rotate monthly, delivering focused case discussions centered on real-world clinical decision-making. Drs. Carol Shields and Sara Lally host each session and lead structured, interactive dialogue that reflects the clinical standards of the program.
Open to all ISOO members. No registration is required. Members join directly using the Zoom link:
https://us06web.zoom.us/j/89965332787?pwd=VaEakhwLzJElJxHbcteZbEn53YOHlX.1
Retinoblastoma Challenging Cases Webinar
Join Dr. Guillermo Chantada and Dr. David Abramson for a live discussion of challenging retinoblastoma cases. This session features 2 cases:
A case from Brazil with orbital disease, with questions on treatment with intra-arterial chemotherapy.
A case from Israel with a discussion of the management of pathological risk factors after enucleation.
The activity is free of charge and open to all ISOO members. No registration is required. Members join directly using the Zoom link:
https://resonancehealth-org.zoom.us/j/87051577776?pwd=kDng8zGZ5OF2ATDr4vcoJ5NyiNFOfq.1
All events are listed in US Eastern Time (EST/EDT). Use this time zone converter for your local time: https://www.timeanddate.com/worldclock/converter.html
60th Ophthalmic Oncology Group (OOG) Meeting
The 60th Ophthalmic Oncology Group Meeting will be held in London, on 2-4 July 2026, with meeting director; Dr Gordon Hay.
MomentUM Seminar: Aqueous Biomarkers from Retinoblastoma to Uveal Melanoma
Dr. Jesse Berry presents on aqueous humor liquid biopsy as a transformative tool in ocular oncology, from retinoblastoma to uveal melanoma. Hosted by the Uveal Melanoma Medico-Scientific Program at Institut Curie, Paris. June 29, 2026, hybrid format. No registration required.
RETINOBLASTOMA: European Retinoblastoma Group (EURbg)
The European Retinoblastoma Group (EURBG) Meeting brings together international ocular oncology specialists to share knowledge and clinical experience on retinoblastoma diagnosis, genetics, conservative treatment, and more. June 12–13, 2026 in Rome, Italy.
Shields Oncology Rounds - April 2026
Shields Oncology Rounds is a landmark case conference hosted by Drs. Carol Shields and Sara Lally, where complex ocular oncology cases are rigorously examined through expert dialogue and refined into definitive care decisions. Virtual, monthly, open to ISOO members.
MomentUM Seminar: Genetics of Uveal Melanoma (Marc-Henri Stern)
Join Dr. Marc-Henri Stern (Institut Curie) for a MomentUM seminar on the genetics of uveal melanoma. No registration required—join via Teams.
13th Annual Ocular Oncology Day
Join together in Italy to exchange ideas, discuss innovative therapies, research projects and results achieved so far.
Webinar: Liquid Biopsy for Retinoblastoma
CCDI webinar on liquid biopsy for retinoblastoma and the LBSeq4Kids platform, featuring Dr. Liya Xu.
Seminar with Prof. Roger Olofsson Bagge
Online seminar featuring Prof. Roger Olofsson Bagge from the Sahlgrenska Academy and University Hospital, Gothenburg.
Title Rb-NET Challenges 2025
The Rb-NET Challenges 2025 is an online webinar for clinicians involved in retinoblastoma care, featuring rapid-fire case presentations from around the world.
Shields' Oncology Rounds
Each month, three fascinating ocular oncology cases are presented and discussed by ophthalmologists from around the world.
INNOVATE Ocular Oncology
A cross-sector forum advancing new therapies, diagnostics, and access in ocular oncology.
AAO 2025 Imagine - Subspecialty Day
This year’s Ocular Oncology and Pathology Subspecialty Day program is titled “Ocular Oncology and Pathology 2025: Seeing Eye to Eye — Ocular Oncology and Pathology Collaborative Debates and Dialogue”.
Benefits and Challenges of Early Detection and Treatment of Uveal Melanoma
Prof. Gustav Stålhammar reviews evidence suggesting early intervention in uveal melanoma may offer a survival advantage.
Uveal Melanoma in 2026: What Do We Know and What’s Ahead of Us?
Prof. Carol Shields discusses advances in uveal melanoma, from diagnostics to new trial developments.
Shields Oncology Rounds
Each month, three fascinating ocular oncology cases are presented and discussed by ophthalmologists from around the world. The session draws an engaged audience of around 100 participants and continues to grow in popularity.
2nd Ocular Oncology Happy Hour Symposium
Two days of Ocular Oncology Sessions on Adult and Pediatric Topics in the Summer Relaxing Atmosphere of Greece.
Virtual attendance is also available!
Ohio Ocular Oncology Symposium
This course will review the latest trends and treatments of patients with rare ocular tumors. Presented by the experts, the course will emphasize practical, clinical pearls that will assist in correct management of complex cases. Updates on ocular surface tumors, retinoblastoma, and a variety of intraocular tumors including uveal melanoma will be offered. The key concepts will be highlighted by representative cases. This course features discussion of clinical pearls derived from challenging and unusual cases. This course is designed for ophthalmologists, residents, fellows, and students
Webinar – Retinoblastoma & Chemotherapy-Induced AML Risk
Join Pediatric Cancer Center Barcelona for a live, expert-led discussion on whether children with retinoblastoma face a higher risk of chemotherapy-induced acute myeloblastic leukemia (AML). Short presentations followed by Q&A. Free and open to clinicians, researchers, and trainees.
Strategies to Improve Retinoblastoma Outcomes in Low Resource Settings
Host/Organizer: SIOP DiSPLeN (Disease Specific Portal for Learning and Networking)
A SIOP DiSPLeN webinar highlighting global strategies for managing retinoblastoma in low-resource settings.
59th Ophthalmic Oncology Group (OOG)
We are thrilled to extend an invitation for the 58th Ophthalmic Oncology Group Meeting, to be held in the beautiful city of Genova, Italy, from April 3rd to 6th, 2025.
The schedule promises an enriching experience, commencing with enlightening lectures on Thursday in collaboration with the Young Investigators Network (YIN) followed by research and clinical sessions. For those staying through Sunday morning, we have organized a social activity as a conclusion to our gathering.
This meeting promises not just knowledge-sharing but also the opportunity for camaraderie. Highlighted by three keynote lectures, attendees will also benefit from several curated meals and interactive social events designed to foster connection and collaboration.
We eagerly await the chance to welcome you in Genova!
Contact Name: Robert Verdijk
Email: r.verdijk@erasmusmc.nl
12th Annual Ocular Oncology Day
Join together in Italy to exchange ideas, discuss innovative therapies, research projects and results achieved so far.
Rb-NET Challenges 2024
We are delighted to invite you to the Rb-NET Challenges 2024 - an online webinar aimed for clinicians engaged in retinoblastoma management.
A 1-hour online webinar for clinicians engaged in retinoblastoma management, in which colleagues from across the world will present short case reports (rapid fire) of challenging RB cases.
In addition, we will have a "real" live MDT meeting (tumor board), including pediatric oncologists, ophthalmologists, pathologists and radiologists. Hoping to see you online.
2nd Annual INNOVATE Ocular Oncology
iVista Medical Education, Inc., along with our Course Director, Prithvi Mruthyunjaya, is excited to invite you to sponsor the 2nd annual INNOVATE Ocular Oncology, scheduled for Saturday, November 2, 2024, at the Stanford Center for Academic Medicine in Palo Alto, California, from 7:00 AM to 5:00 PM PT.
INNOVATE Ocular Oncology continues in the tradition of our INNOVATE series, where scientific, clinical, and industry leaders come together to educate and inform participants on the state-of-the-art and future trends in ocular oncology. This is a critical time in this field- even with the approval of new therapies, increased clinical trial options, and advanced diagnostics, there are still unmet needs regarding treatment burden, toxicities, and access to care. INNOVATE Ocular Oncology aims to address these issues head-on with provocative lectures, cutting-edge research presentations, and panel discussions with leaders in biopharma. The hallmark of this meeting rests with hard questions, lively discussion, and a collegial inter-disciplinary environment.